BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

metrics 2024

Unlocking Innovations in Health Sciences

Introduction

The BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, published by the ASSOC BRAS DIVULG CIENTIFICA, serves as a vital platform for the dissemination of cutting-edge research in the fields of medicine and biological sciences. With an ISSN of 0100-879X and E-ISSN 1414-431X, this Open Access journal has been championing free access to vital scientific knowledge since 1997. It is indexed in Scopus with notable rankings across various disciplines, including a rank of #131 in General Medicine (79th percentile) and #20 in Pharmacology, Toxicology, and Pharmaceutics (75th percentile). Covering a broad scope of topics, the journal primarily focuses on areas such as biochemistry, biophysics, immunology, neuroscience, and physiology, with a commendable categorization of Q2 and Q3 quartiles for several relevant fields in 2023. Through its commitment to high-quality research and robust peer review processes, the journal not only consolidates its reputation within the academic community but also significantly contributes to the enhancement of scientific knowledge and innovation in Brazil and beyond. Researchers, professionals, and students will find an invaluable resource in this journal, which is pivotal for those looking to stay abreast of the latest developments in medical and biological research.

Metrics 2024

SCIMAGO Journal Rank0.49
Journal Impact Factor1.90
Journal Impact Factor (5 years)2.10
H-Index98
Journal IF Without Self1.90
Eigen Factor0.00
Normal Eigen Factor0.58
Influence0.43
Immediacy Index0.40
Cited Half Life10.90
Citing Half Life8.60
JCI0.50
Total Documents4358
WOS Total Citations5531
SCIMAGO Total Citations20496
SCIMAGO SELF Citations479
Scopus Journal Rank0.49
Cites / Document (2 Years)1.95
Cites / Document (3 Years)2.12
Cites / Document (4 Years)2.34

Metrics History

Rank 2024

Scopus

General Medicine in Medicine
Rank #131/636
Percentile 79.40
Quartile Q1
General Pharmacology, Toxicology and Pharmaceutics in Pharmacology, Toxicology and Pharmaceutics
Rank #20/80
Percentile 75.00
Quartile Q2
Biophysics in Biochemistry, Genetics and Molecular Biology
Rank #77/152
Percentile 49.34
Quartile Q3
General Neuroscience in Neuroscience
Rank #68/113
Percentile 39.82
Quartile Q3
Physiology in Biochemistry, Genetics and Molecular Biology
Rank #119/193
Percentile 38.34
Quartile Q3
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #278/438
Percentile 36.53
Quartile Q3
Immunology in Immunology and Microbiology
Rank #157/236
Percentile 33.47
Quartile Q3
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #214/285
Percentile 24.91
Quartile Q4

IF (Web Of Science)

BIOLOGY
Rank 52/109
Percentile 52.80
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 127/189
Percentile 33.10
Quartile Q3

JCI (Web Of Science)

BIOLOGY
Rank 59/109
Percentile 45.87
Quartile Q3
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 122/189
Percentile 35.45
Quartile Q3

Quartile History

Similar Journals

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Exploring Innovations in Experimental Biology and Medicine
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

BioImpacts

Navigating contemporary challenges through cutting-edge studies.
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5652Frequency: 4 issues/year

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

COMPTES RENDUS BIOLOGIES

Advancing Knowledge in Biological Sciences
Publisher: ACAD SCIENCESISSN: 1631-0691Frequency: 4 issues/year

COMPTES RENDUS BIOLOGIES, published by the esteemed Académie des Sciences, is a prominent journal based in France that contributes significantly to the fields of Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, as well as Immunology and Microbiology. With a notable Q3 ranking in several categories as of 2023, this journal serves as an essential platform for disseminating groundbreaking research and advancements in these disciplines. Access is currently available under open access options, enhancing the reach and accessibility of its published findings. The journal has been in continuous publication since 1959, with a current focus extending to 2024, ensuring that it remains at the forefront of scientific communication. With its diverse scope and commitment to quality research, COMPTES RENDUS BIOLOGIES plays a crucial role in fostering dialogue and collaboration among researchers, professionals, and students who are dedicated to understanding and addressing complex biological questions.

LIFE SCIENCES

Elevating the discourse in molecular biology and medicine.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0024-3205Frequency: 24 issues/year

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.

FEBS Open Bio

Unlocking the potential of open-access scientific discovery.
Publisher: WILEYISSN: 2211-5463Frequency: 1 issue/year

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

Marmara Medical Journal

Transforming Healthcare Challenges into Research Opportunities.
Publisher: MARMARA UNIV, FAC MEDICINEISSN: 1309-9469Frequency: 4 issues/year

Marmara Medical Journal, published by Marmara University, Faculty of Medicine, is a peer-reviewed academic journal that has been a significant platform for the dissemination of medical research since its inception in 1996. With an ISSN of 1309-9469, this journal operates from Turkey and serves the global medical community with a commitment to advancing medical knowledge and practice. Although currently classified in the Q4 category in the field of Medicine (Miscellaneous) and ranked at the 18th percentile in Scopus, Marmara Medical Journal embraces a broad scope by including diverse topics within the medical sciences, which fosters interdisciplinary research. Researchers and practitioners are encouraged to contribute by submitting their findings, fostering a dynamic exchange of knowledge. Our mission is to support both new and established medical professionals in addressing contemporary healthcare challenges through rigorous research, thus enhancing the impact of medical literature in Turkey and beyond.

International Journal of Medical Sciences

Connecting researchers to elevate the field of medical sciences.
Publisher: IVYSPRING INT PUBLISSN: 1449-1907Frequency: 12 issues/year

International Journal of Medical Sciences is a leading peer-reviewed journal dedicated to advancing the field of medicine through the dissemination of high-quality research. Published by IVYSPRING INT PUBL in Australia, this open-access journal has been accessible to the global community since 2004, allowing for unrestricted distribution of research findings. With an impressive impact in the medical field, it ranks in the Q2 category for Miscellaneous Medicine and is placed at #55 out of 636 journals in the Scopus rankings, reflecting its commitment to excellence as evidenced by its 91st percentile standing. The journal serves as a vital platform for researchers, professionals, and students alike, fostering collaboration and innovation within the medical sciences. The International Journal of Medical Sciences invites contributions that explore diverse areas within the medical domain and emphasizes the importance of interdisciplinary approaches to solving complex health challenges.

MedComm

Championing Transparency in Scientific Publishing
Publisher: WILEYISSN: Frequency: 4 issues/year

MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.

Stem Cell Research & Therapy

Exploring Breakthroughs in Stem Cell Biology
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Open Life Sciences

Connecting Researchers to a World of Discovery
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2391-5412Frequency: 1 issue/year

Open Life Sciences is a distinguished open-access journal published by DE GRUYTER POLAND SP Z O O, dedicated to advancing research across diverse disciplines in the life sciences. Since its inception in 2014 and transitioning to open access in 2015, the journal has become a pivotal platform for researchers, fostering the dissemination of high-quality scientific work while ensuring that valuable findings are freely accessible to the global community. With an impressive categorization into Q2 in Agricultural and Biological Sciences and Q3 in several other fields including Biochemistry and Immunology as of 2023, Open Life Sciences promotes innovation and knowledge sharing across its broad spectrum of topics. The journal's commitment to excellence is reflected in its competitive Scopus rankings, making it an essential resource for professionals and students alike who are keen to stay at the forefront of life sciences research.